Co-Diagnostics, Inc. Breakthrough CoPrimer™ Technology to be Featured at PAG XXVIII

Date : 01/07/2020 @ 11:30AM
Source : Business Wire
Stock : Co Diagnostics Inc (CODX)
Quote : 8.26  -0.89 (-9.73%) @ 6:22PM
Co Diagnostics share price Chart

Co-Diagnostics, Inc. Breakthrough CoPrimer™ Technology to be Featured at PAG XXVIII

Co Diagnostics (NASDAQ:CODX)
Historical Stock Chart

3 Months : From Dec 2019 to Mar 2020

Click Here for more Co Diagnostics Charts.

Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that the Company’s groundbreaking Co-Diagnostics CoPrimer™ technology will be featured at the International Plant & Animal Genome XXVIII conference, held on January 11-15 in San Diego, CA.

The evaluation of BHQplex™ CoPrimers in flexible PCR-based genotyping will be presented by a representative of Bayer - Crop Science on Monday, January 13, in a presentation titled “CoPrimer Assays for Multiplex PCR.” According to the presentation abstract, Bayer evaluated the patented technology’s ability to enable robust and flexible multiplexing for PCR-based genotyping in several assays. This included successfully testing their performance in many different combinations and plex-levels using qPCR, end-point and digital PCR. BHQplex CoPrimers utilize the Company’s patented CoPrimer technology as branded by LGC Biosearch, whose footprint covers over 200 countries.

The Company intends to provide additional information concerning the importance of these findings following the presentation.

More information about the PAG conference can be found on the conference website.

About Co-Diagnostics, Inc.:

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company’s technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

Forward-Looking Statements:

This press release contains forward-looking statements. Forward-looking statements can be identified by words such as "believes," "expects," "estimates," "intends," "may," "plans," "will" and similar expressions, or the negative of these words. Such forward-looking statements are based on facts and conditions as they exist at the time such statements are made and predictions as to future facts and conditions. Forward-looking statements in this release may include statements regarding the (i) use of funding proceeds, (ii) expansion of product distribution, (iii) acceleration of initiatives in certain verticals or markets, (iv) capital resources and runway needed to advance the Company’s products and markets, (v) increased sales in the near-term, (vi) flexibility in managing the Company’s balance sheet, (vii) anticipation of business expansion, and (viii) benefits in research and worldwide accessibility of the CoPrimer technology and its cost-saving and scientific advantages. Forward-looking statements are subject to inherent uncertainties, risks and changes in circumstances. Actual results may differ materially from those contemplated or anticipated by such forward-looking statements. Readers of this press release are cautioned not to place undue reliance on any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statement relating to matters discussed in this press release, except as may be required by applicable securities laws.

Andrew Benson Head of Investor Relations +1 801-438-1036 investors@codiagnostics.com

Latest CODX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
$
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20200330 17:38:03